Glucosidase inhibitor, LTI-291, Purity ≥98%

Synonym: 1919820-28-2; LTI 291; LTI291; 5,7-Dimethyl-N-(4-pentoxycyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide; Glucosidase inhibitor

CAS Number: 1919820-28-2
Compound CID: 121327414

Product Size

5 mg; 10 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

LTI-291, soluble in DMSO and ethanol and insoluble in water, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting glucosidase. The molecular weight of the compound is 358.48, and its molecular formula is C₂₀H₃₀N₄O₂.

Molecular Weight

358.48

Molecular Formula

C₂₀H₃₀N₄O₂

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: DMSO: 31 mg/mL (86.47 mM); Water: insoluble; Ethanol: 62 mg/mL (172.95 mM)

Identity

Confirmed by NMR/HPLC/MS.

Applications

LTI-291 can be studied extensively for its potential therapeutic applications in the treatment of type 2 diabetes, helping to control postprandial blood glucose levels.